Koyfin Home > Directory > Health Care > Amneal Pharmaceuticals Inc > Total Debt / EBITDA

Amneal Pharmaceuticals Inc Total Debt / EBITDA Chart (AMRX)

Amneal Pharmaceuticals Inc annual/quarterly Total Debt / EBITDA from 2016 to 2018.
  • Amneal Pharmaceuticals Inc Total Debt / EBITDA for the quarter ending December 12, 2018 was $6m a 29.78% increase of 2m year over year
  • Amneal Pharmaceuticals Inc Total Debt / EBITDA for the last 12 months ending December 12, 2018 was $7m a 30.47% increase of 2m year over year
  • Amneal Pharmaceuticals Inc Annual Total Debt / EBITDA for 2018 was $7m a 22.66% increase of 1m from 2017
  • Amneal Pharmaceuticals Inc Annual Total Debt / EBITDA for 2017 was $5m a 22.56% increase of 1m from 2016
  • Amneal Pharmaceuticals Inc Annual Total Debt / EBITDA for 2016 was $4m a -2.63% decrease of 0m from 2015
Other Ratios Metrics:
  • Amneal Pharmaceuticals Inc Total Debt / Capital for the quarter ending December 12, 2018 was $75m a -77.49% decrease of -58m year over year
  • Amneal Pharmaceuticals Inc Other Liabilities for the quarter ending December 12, 2018 was $233m a 90.39% increase of 210m year over year
  • Amneal Pharmaceuticals Inc Total Debt / Equity for the quarter ending December 12, 2018 was $300m
View Chart On Koyfin

Quarterly AMRX Total Debt / EBITDA Data

12/2018$6m
09/2018$5m
06/2018$7m
03/2018$4m
12/2017$4m
09/2017$5m
03/2017$6m
12/2016$3m

Annual AMRX Total Debt / EBITDA Data

2018$7m
2017$5m
2016$4m
2015$4m